Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.56 |
| ▸ | PCNA | P12004 | 1/20 | 0.53 |
| ▸ | LTA4H | P09960 | 2/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.47 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.47 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.47 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.47 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.47 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.47 |
| ▸ | MMP12 | P39900 | 1/20 | 0.46 |
| ▸ | MMP13 | P45452 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.45 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9394667 | 0.90 | SLC7A5 (0.67) | SLC7A5GRIK1GRIA1GRIA2GRIA3 | |
| SCHEMBL1666620 | 0.90 | SLC7A5 (0.67) | SLC7A5GRIK1GRIA1GRIA2GRIA3 | |
| SCHEMBL1768639 | 0.90 | SLC7A5 (0.67) | SLC7A5GRIK1GRIA1GRIA2GRIA3 | |
| Bromide SCHEMBL29399073 | 0.89 | SLC7A5 (0.65) | SLC7A5GRIK1GRIA1GRIA2GRIA3 | |
| Bromide SCHEMBL919214 | 0.89 | SLC7A5 (0.65) | SLC7A5GRIK1GRIA1GRIA2GRIA3 | |
| SCHEMBL22851020 | 0.87 | SLC7A5 (0.51) | SLC7A5PCNALTA4HGRIK1GRIA1 | |
| SCHEMBL285216 | 0.84 | SLC7A5 (0.80) | SLC7A5PCNAKDM4EUSP2EGFR | |
| SCHEMBL30622075 | 0.84 | SLC7A5 (0.80) | SLC7A5PCNAKDM4EUSP2EGFR | |
| SCHEMBL285217 | 0.84 | SLC7A5 (0.80) | SLC7A5PCNAKDM4EUSP2EGFR | |
| SCHEMBL29556905 | 0.84 | SLC7A5 (0.80) | SLC7A5PCNAKDM4EUSP2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11118011-B2 | Biocompatible polymers for medical devices | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2021-09-14 | — | — | US | disclosed |
| EP-3461855-B1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | UNIV RUTGERS (US) | 2020-05-27 | — | — | EP | disclosed |
| US-20190185624-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2019-06-20 | — | — | US | disclosed |
| EP-3461855-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | Rutgers, The State University of New Jersey (US) | 2019-04-03 | — | — | EP | disclosed |
| US-10202490-B2 | Biocompatible polymers for medical devices | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2019-02-12 | — | — | US | disclosed |
| EP-2486081-B1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | UNIV RUTGERS (US) | 2018-12-05 | — | — | EP | disclosed |
| US-20170158819-A1 | BIOCOMPATIBLE POLYMERS FOR MEDICAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2017-06-08 | — | — | US | disclosed |
| US-9605112-B2 | Biocompatible polymers for medical devices | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2017-03-28 | — | — | US | disclosed |
| US-20120226013-A1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2012-09-06 | — | — | US | disclosed |
| EP-2486081-A1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | Rutgers, The State University of New Jersey (US) | 2012-08-15 | — | — | EP | disclosed |
| WO-2011044567-A1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2011-04-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120226013-A1 | BIOCOMPATIBLE POLYMERS FOR MEDIAL DEVICES | MATR3, MIF, BMP2 | SLC7A5 2373/4885PCNA 187/4885LTA4H 1151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.